Get started
PFIZER INCPFIZER INCPFIZER INC

PFIZER INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

PFE trade ideas

Pfizer D1Pfizer is one of the largest pharmaceutical companies in the world. Its shares are among the first echelon of the American market. Companies with the largest capitalization. To date, the company's vaccine against coronavirus is the most effective. What allows the company to pick up the main market. To date, the progression of the disease is very intense. Over the past month, the number of patients has increased by 20 percent. From 100,000,000 it reached 120,000,000 people. You need to understand that the situation with the disease will not end very quickly. And this will be a good chance for the company to capitalize on this. Moreover, you need to understand that in many countries draft laws on compulsory excitation are being developed. That will enable the company to receive large government contracts worth millions and billions of dollars. That will be a good incentive for the growth of stocks.
NYSE:PFELong
by TradingForProfitPro
1
It is finally time for PFE?After many years of consolidation is PFE finally got "star" fame? Like we can see monthly chart it's almost close to make a beautiful reversal Head and Shoulder chart for strong push up on fundamentals wings. As pandemic subside and hope that Covid-19 pass through behind ours backs, forward P/E and revenues is strong on PFE side, so buy area will be good setup for as the Redditors would say "PFE to the moon" haha... Thank you very much for reading, if you see that this chart is interesting and feel free to press like and comment, every comment is welcome :) NYSE:PFE
NYSE:PFELong
by kova137
PfizerPfizer's revenues for Q4 and the year announced last week are up 8% in 2020. Pfizer's $ 1.56 annual dividend payout currently corresponds to a 4.5% yield. These returns are well above the S&P 500 average. As of February 2021, Pfizer has 95 completed projects, 24 of which are in phase 3. Pfizer expects 2021 to be a record year with revenues ranging from $ 60 billion to $ 61 billion. The COVID-19 vaccine business will be profitable consistently in 2021 and beyond. The obvious risk today for Pfizer and the profitability of the pharmaceutical industry in general is the Biden administration's plans to reform healthcare and cut costs. Based on current fundamentals, Pfizer shares should again bounce off $ 34 and may well reach $ 37 and $ 42, respectively. Investment idea. Share your opinion in the comments and support the idea with likes. Thank you for your support!
NYSE:PFELong
by monsRUS
5
PFE - Wedge breakout target $39PFE is in descending wedge. IF breakout happen, near term potential target is $39. Entry - below $35 Exit - 30% $39, 30% $43, 40% - $55 Worst case - $32.79 ——————————————————— How to read my charts? - Matching color trend lines shows the pattern. Sometimes a chart can have multiple patterns. Each pattern will have matching color trend lines. - The yellow horizontal lines shows support and resistance areas. - Fib lines also shows support and resistance areas. - The dotted white lines shows price projection for breakout or breakdown target. Disclaimer: Do your own DD. Not an investment advice.
NYSE:PFE
by PaperBozz